Literature DB >> 27353274

Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.

Josephin Mosch1,2, Christian A Gleissner2, Simon Body3, Elena Aikawa1,4.   

Abstract

BACKGROUND: Calcific aortic valve disease (CAVD) is the most common valvular heart disease and likely evolves from inflammatory pre-conditions in the valve. Type II diabetes mellitus (DMII) has been associated with pathogenesis of CAVD, however, the mechanism initiating CAVD in DMII is not well understood and the human valve pathology in DMII has not been described. We therefore performed quantitative histological analyses of aortic valves of CAVD patients with and without DMII.
METHODS: CAVD human aortic valves (n=45) obtained after surgical valve replacement were examined macroscopically with gross measurements of calcified areas. Inflammation and calcification were assessed by immunohistochemistry and immunofluorescence staining.
RESULTS: Calcification was increased in diabetic patients according to gross measurements (p<0.01) and alizarin red staining (p=0.05). Early calcification markers, including Runx2 (p=0.02) and alkaline phosphatase (ALP, p=0.03) were significantly elevated in diabetic patients. Furthermore, in diabetic patients we found significantly increased expression of annexin II (p=0.04) and annexin V (p=0.04), both of which are thought to play a role in microcalcification formation via apoptosis or extracellular vesicle release. Macrophage numbers were comparable in both groups (p=0.41), while the expression of the pro-inflammatory protein S100A9 (p<0.01) was significantly decreased in diabetic individuals. Evaluation of lymphocytes revealed similar CD8 (p=0.45) and CD4 (p=0.92) T cell counts in diabetic and non-diabetic aortic valves.
CONCLUSION: Aortic valves from diabetic patients show more calcification, while inflammation is similar in both patient populations. Considering the generally accepted theory of an inflammation-dependent mechanism of calcification, these data suggest that in patients with CAVD requiring valve replacement, diabetic patients could be molecularly in a more advanced disease stage with a higher grade of mineralization than non-diabetic patients.

Entities:  

Mesh:

Year:  2016        PMID: 27353274      PMCID: PMC5199639          DOI: 10.14670/HH-11-797

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  66 in total

1.  The crystal structure of a complex of p11 with the annexin II N-terminal peptide.

Authors:  S Réty; J Sopkova; M Renouard; D Osterloh; V Gerke; S Tabaries; F Russo-Marie; A Lewit-Bentley
Journal:  Nat Struct Biol       Date:  1999-01

2.  Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.

Authors:  Anders Green; Dena Rosen Ramey; Martha Emneus; Maria Iachina; Knut Stavem; Kristian Bolin; Richard McNally; Michael Busch-Sørensen; Ronnie Willenheimer; Kenneth Egstrup; Y Antero Kesäniemi; Simon Ray; Nermine Basta; Christi Kent; Terje R Pedersen
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

Review 3.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

Review 4.  Annexins: linking Ca2+ signalling to membrane dynamics.

Authors:  Volker Gerke; Carl E Creutz; Stephen E Moss
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

5.  Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.

Authors:  Ling Yan; Marion A Hofmann Bowman
Journal:  Inflamm Cell Signal       Date:  2014

6.  Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin.

Authors:  Gerben Bouma; Wai Kwan Lam-Tse; Annet F Wierenga-Wolf; Hemmo A Drexhage; Marjan A Versnel
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

7.  Mechanisms by which diabetes increases cardiovascular disease.

Authors:  Christian A Gleissner; Elena Galkina; Jerry L Nadler; Klaus Ley
Journal:  Drug Discov Today Dis Mech       Date:  2007

8.  Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; C J Dalsgaard; A Haegerstrand; M Rosenqvist; L Rydén; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

9.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.

Authors:  David A Morrow; Yunmei Wang; Kevin Croce; Masashi Sakuma; Marc S Sabatine; Huiyun Gao; Aruna D Pradhan; Aileen M Healy; Jacki Buros; Carolyn H McCabe; Peter Libby; Christopher P Cannon; Eugene Braunwald; Daniel I Simon
Journal:  Am Heart J       Date:  2007-11-01       Impact factor: 4.749

View more
  9 in total

1.  Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.

Authors:  Marta Scatena; Melissa F Jackson; Mei Y Speer; Elizabeth M Leaf; Mary C Wallingford; Cecilia M Giachelli
Journal:  Cardiovasc Pathol       Date:  2018-02-15       Impact factor: 2.185

Review 2.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

3.  Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.

Authors:  Alexia Hulin; Alexandre Hego; Patrizio Lancellotti; Cécile Oury
Journal:  Front Cardiovasc Med       Date:  2018-03-14

4.  Placental Vascular Calcification and Cardiovascular Health: It Is Time to Determine How Much of Maternal and Offspring Health Is Written in Stone.

Authors:  Mary C Wallingford; Ciara Benson; Nicholas W Chavkin; Michael T Chin; Martin G Frasch
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.755

5.  Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001-2015).

Authors:  Ana López-de-Andrés; Napoleon Perez-Farinos; Javier de Miguel-Díez; Valentín Hernández-Barrera; Manuel Méndez-Bailón; José M de Miguel-Yanes; Rodrigo Jiménez-García
Journal:  Cardiovasc Diabetol       Date:  2018-10-16       Impact factor: 9.951

Review 6.  Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.

Authors:  Brunilda Alushi; Lavinia Curini; Mary Roxana Christopher; Herko Grubitzch; Ulf Landmesser; Amedeo Amedei; Alexander Lauten
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

7.  Role of endothelial CXCR4 in the development of aortic valve stenosis.

Authors:  Anna Winnicki; James Gadd; Vahagn Ohanyan; Gilbert Hernandez; Yang Wang; Molly Enrick; Hannah McKillen; Matthew Kiedrowski; Dipan Kundu; Karlina Kegecik; Marc Penn; William M Chilian; Liya Yin; Feng Dong
Journal:  Front Cardiovasc Med       Date:  2022-09-06

8.  Effects of Altering Mitochondrial Antioxidant Capacity on Molecular and Phenotypic Drivers of Fibrocalcific Aortic Valve Stenosis.

Authors:  Carolyn M Roos; Bin Zhang; Michael A Hagler; Grace C Verzosa; Runqing Huang; Elise A Oehler; Arman Arghami; Jordan D Miller
Journal:  Front Cardiovasc Med       Date:  2021-06-24

Review 9.  Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.

Authors:  Ileana Manduteanu; Dan Simionescu; Agneta Simionescu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2021-09-24       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.